Robert Brody
AstraZeneca
9 Papers
23 Citations
Robert Brody is an academic researcher from AstraZeneca. The author has contributed to research in topics: Population & Lung cancer. The author has an hindex of 4, co-authored 9 publications.
Chat about Author
Papers
Effectiveness of a risk-minimization activity involving physician education on metabolic monitoring of patients receiving quetiapine: results from two postauthorization safety studies
Robert Brody,Charles L. Liss,Heather Wray,Ramon Iovin,Carmen Michaylira,Anushini Muthutantri,Philip Damstetter,Catherine Datto,Leigh Jefferies +8 more
TL;DR: The monitoring activities observed were assessed as acceptable on the basis of the established performance of UK physicians, who are incentivized to deliver preventive screening.
12
Impact of increased influenza vaccination in 2–3-year-old children on disease burden within the general population: A Bayesian model-based approach
Sankarasubramanian Rajaram,Witold Więcek,Richard Lawson,Betina T. Blak,Yanli Zhao,Judith Hackett,Robert Brody,Vishal Patel,Billy Amzal +8 more
TL;DR: Evidence is provided that extending routine influenza vaccination to all healthy children aged 2 and 3 years old leads to benefits in terms of reduced utilization of healthcare resources and fewer respiratory health outcomes and deaths.
Treatment Patterns, Healthcare Resource Utilization and Costs in Patients With Bipolar Disorder, Newly Treated With Extended Release or Immediate Release Quetiapine Fumarate Using US Healthcare Administrative Claims Data
Julie C. Locklear,Berhanu Alemayehu,Robert Brody,Soheil Chavoshi,Ozgur Tunceli,David M. Kern,Willie Earley +6 more
TL;DR: Treatment patterns and dosing differ in patients with bipolar disorder treated with quetiapine XR compared with those treated with QuetiAPine IR, and mental health-related hospitalizations and costs may be reduced in the 12 months after patients initiating treatment with quetsiapines XR.
8
Results from a drug utilization study of extended release quetiapine fumarate prescribed by psychiatrists as treatment for major depressive disorder in selected countries in the European Union.
Robert Brody,Charles L. Liss,Heather Wray,Kari Kastango,Allison Bryant,Alban Fabre,Anneli Thuresson +6 more
TL;DR: This analysis demonstrated similarities in DU across the countries analyzed, largely in accordance with the recommended dose of quetiapine XR as an adjunctive therapy to antidepressants in MDD (50–300 mg/day).
2
A retrospective observational analysis of post-pandemic influenza-related outcomes in the United Kingdom, 2010-2014.
Sankarasubramanian Rajaram,Witold Więcek,Richard Lawson,Betina T. Blak,Yanli Zhao,Judith Hackett,Robert Brody,Tehseen Salimi,Billy Amzal,Vishal Patel +9 more
TL;DR: This study provides valuable insight into the incidence of influenza- and respiratory-related diagnoses in the primary care setting in England, and suggests a higher burden of disease in young children and the elderly.
2